Money Talk

Syngene: Heavy investment phase makes it a long-term play

Syngene: Heavy investment phase makes it a long-term play Beyond contract research, another trend to watch for Syngene is the pick-up in contract manufacturing business in biologics and APIs

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s